CLARIFICATION: Cepheid Stock Continues to Climb as Anthrax Reported on West Coast | GenomeWeb

This article previously reported that Cepheid's technology is being used by government health and law-enforcement officials in New York, Nevada, and Florida to investigate reports of anthrax. While Cepheid acknowledges that its DNA-analysis instruments are being used by these agencies, the company cannot comment whether the products are being used in any specific anthrax case in those states.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."